Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 87101-87150 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05910385
TUbal LIgation Per Differents Endoscopic Routes and Sexuality (TULIPES)
NAActive, not recruiting
140 participants
Started: May 23, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor2 locations
NCT05428605
In Vitro Immunomodulation in Membranous Nephropathy Relapses
NARecruiting
20 participants
Started: May 23, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05257590
CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular Carcinoma
PHASE2Recruiting
95 participants
Started: May 23, 2022 · Completed: Mar 31, 2026
2 conditions1 sponsor5 locations
NCT05803616
Liquid Biopsy to Enable Diagnostics and Monitoring for Immune-mediated Lymphoproliferative Disorders
N/ARecruiting
20 participants
Started: May 23, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor6 locations
NCT05430373
GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors
PHASE1Recruiting
31 participants
Started: May 23, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor5 locations
NCT05534906
The Detection of Small Early Liver Cancer With Natural History Follow up
N/ARecruiting
250 participants
Started: May 23, 2022 · Completed: Jun 30, 2035
1 condition7 sponsors1 location
NCT05236439
Study of a Cilioscleral Interposition Device (CID) SV22 in Patients With Primary Open Angle Glaucoma and Narrow Angle Glaucoma
NAActive, not recruiting
57 participants
Started: May 23, 2022 · Completed: Dec 15, 2025
2 conditions2 sponsors1 location
NCT06680362
The Influence of Splenic Artery Characteristics in Gastric Cancer Surgery
N/AActive, not recruiting
176 participants
Started: May 22, 2022 · Completed: Oct 31, 2024
2 conditions1 sponsor1 location
NCT05472402
Feasibility and Acceptability of an Online Program to Promote Physical Activity Among Black Women
NAActive, not recruiting
60 participants
Started: May 22, 2022 · Completed: Nov 30, 2025
3 conditions1 sponsor1 location
NCT06111820
Evaluation of Training Curriculum and Service of Improving Access to Community Therapies
NARecruiting
330 participants
Started: May 22, 2022 · Completed: Sep 30, 2024
5 conditions2 sponsors21 locations
NCT05447923
Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities
NARecruiting
450 participants
Started: May 22, 2022 · Completed: Jun 1, 2030
1 condition1 sponsor1 location
NCT05263804
CoHort of Patients to Identify Biological and Imaging markerS of CardiovascUlar Outcomes in Stroke - HIBISCUS-STROKE II
NARecruiting
500 participants
Started: May 22, 2022 · Completed: Jun 30, 2029
1 condition1 sponsor1 location
NCT05339568
Patient's Whole Process Follow-up Management(HOPE-1)
N/ARecruiting
1,268 participants
Started: May 22, 2022 · Completed: Aug 20, 2030
2 conditions1 sponsor1 location
NCT04342715
A Study to Assess Immune Response Status in Patients Before and After Treatment for Visceral Leishmaniasis
N/AActive, not recruiting
216 participants
Started: May 22, 2022 · Completed: Mar 31, 2026
1 condition7 sponsors1 location
NCT06777030
Role of Exosomes in Pancreatic Cancer Progression
N/ARecruiting
60 participants
Started: May 22, 2022 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT05066711
NuVasive® ACP System Study
N/AEnrolling by invitation
75 participants
Started: May 22, 2022 · Completed: Jan 30, 2026
7 conditions1 sponsor3 locations
NCT05304377
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
PHASE1Recruiting
200 participants
Started: May 22, 2022 · Completed: Dec 31, 2026
3 conditions1 sponsor46 locations
NCT04654013
PROductivity Study of Presbyopia Elimination in Rural-dwellers III
NAActive, not recruiting
1,291 participants
Started: May 21, 2022 · Completed: Jun 5, 2025
1 condition6 sponsors1 location
NCT05253911
Tucatinib in Patients With Locally Advanced or Metastatic HER2-positive Breast Cancer Who Received at Least Two Prior Anti-HER2 Treatment Regimens.
N/ARecruiting
300 participants
Started: May 21, 2022 · Completed: May 31, 2027
1 condition2 sponsors2 locations
NCT05698862
Mapping the Impact of Gut Microbiota on Brain and Behavior Through the Lens of GABA
NARecruiting
60 participants
Started: May 21, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05089721
Questionnaire for Obstetricians and Anesthesiologist
N/AActive, not recruiting
200 participants
Started: May 21, 2022 · Completed: Feb 21, 2025
3 conditions1 sponsor1 location
NCT05539716
Metabolism and Sleep Apnea Treatment
NARecruiting
100 participants
Started: May 20, 2022 · Completed: Sep 1, 2026
2 conditions2 sponsors1 location
NCT05351476
Exercise Training and Fat Metabolism in Postmenopausal Women
NARecruiting
120 participants
Started: May 20, 2022 · Completed: Apr 30, 2027
3 conditions4 sponsors1 location
NCT05437939
Adverse Outcomes Following Female Genital Fistula Repair
N/AActive, not recruiting
802 participants
Started: May 20, 2022 · Completed: Jul 31, 2026
2 conditions4 sponsors1 location
NCT05387655
Long Term Effects of BCG Vaccination on Infectious and Immune Mediated Diseases
N/AActive, not recruiting
4,292 participants
Started: May 20, 2022 · Completed: Jun 20, 2027
4 conditions2 sponsors1 location
NCT06310928
The Effect of Thermal Blanket After Peripheral Artery Surgery
NARecruiting
60 participants
Started: May 20, 2022 · Completed: Mar 31, 2024
1 condition1 sponsor1 location
NCT05312892
Sympathetic Mechanisms in Obesity-Crossover Design
PHASE1/PHASE2Recruiting
12 participants
Started: May 20, 2022 · Completed: Dec 31, 2029
2 conditions1 sponsor1 location
NCT05393804
A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant
PHASE2Recruiting
32 participants
Started: May 20, 2022 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT04513288
ICITRU : Randomized Trial of Immunonutrition With L-citrulline in Patients Hospitalized in Intensive Care for Sepsis or Septic Shock
NARecruiting
130 participants
Started: May 20, 2022 · Completed: Nov 20, 2026
2 conditions1 sponsor5 locations
NCT05218447
Dosing of Overground Robotic Gait Training with Functional Outcomes and Neuroplasticity After Spinal Cord Injury
NARecruiting
144 participants
Started: May 20, 2022 · Completed: Sep 14, 2025
1 condition3 sponsors1 location
NCT04775160
Smartphone-based Ecological Momentary Intervention for Suicide Prevention: a Randomised Clinical Trial
NANot yet recruiting
220 participants
Started: May 20, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05324579
Studying the Neuronal Basis of Human Social Cognition
NARecruiting
20 participants
Started: May 20, 2022 · Completed: Jun 1, 2026
1 condition2 sponsors2 locations
NCT04316546
MK-7075 (Miransertib) in Proteus Syndrome
PHASE2Recruiting
45 participants
Started: May 20, 2022 · Completed: Mar 31, 2028
1 condition1 sponsor1 location
NCT05163600
The Acute Cardiorespiratory Response to Blood-flow Restricted Versus Traditional Exercise Training Regimens (CaRe BFR)
NARecruiting
24 participants
Started: May 20, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05593081
Multicenter Study of Fulminant Type 1 Diabetes in China
N/ARecruiting
240 participants
Started: May 20, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor10 locations
NCT04792931
Adult Autoimmune Myopathies (MAIA)
NARecruiting
60 participants
Started: May 20, 2022 · Completed: May 20, 2030
1 condition1 sponsor1 location
NCT06020040
Bone Particles Sizes and the Stability of Soft and Hard Tissue in Aesthetic Area
NAActive, not recruiting
50 participants
Started: May 20, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06031025
Prevalence and Natural History of Functional Gastrointestinal Disorders Among At-risk Infants.
N/ARecruiting
71 participants
Started: May 20, 2022 · Completed: Sep 30, 2025
7 conditions1 sponsor1 location
NCT05192057
Hypertonic Saline Inhalation for Mycobacterium Avium Complex Pulmonary Disease
PHASE4Recruiting
30 participants
Started: May 20, 2022 · Completed: Oct 1, 2026
2 conditions1 sponsor1 location
NCT05479812
Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors
PHASE1Recruiting
150 participants
Started: May 20, 2022 · Completed: Jul 31, 2026
2 conditions2 sponsors14 locations
NCT05868486
Analysis of Whole Body Magnetic Resonance Imaging and Liquid Biopsy for Early Detection of Cancer in Patients With a Strong Family History of Cancer
EARLY_PHASE1Active, not recruiting
100 participants
Started: May 20, 2022 · Completed: Nov 19, 2025
2 conditions2 sponsors1 location
NCT04745403
Redirected HBV-Specific T Cells in Patients With HBV-related HCC (SAFE-T-HBV)
PHASE1Recruiting
10 participants
Started: May 20, 2022 · Completed: Jul 1, 2028
1 condition1 sponsor1 location
NCT04865172
ECOCAPTURE for the Assessment of Apathy Under Real-life Conditions
N/ARecruiting
120 participants
Started: May 20, 2022 · Completed: May 31, 2025
2 conditions1 sponsor1 location
NCT05351788
SKB264 Combinatiton Therapy in Patients With Advanced or Metastatic Non-small Cell Lung Cancer.
PHASE2Recruiting
110 participants
Started: May 20, 2022 · Completed: Apr 30, 2026
1 condition1 sponsor2 locations
NCT05134428
A First in Human Study, Evaluating the Safety and Efficacy of ADAM™ 1.0
NAActive, not recruiting
25 participants
Started: May 20, 2022 · Completed: Feb 20, 2026
2 conditions1 sponsor3 locations
NCT06097065
Research on Potential Biomarkers of Prediabetes and Diabetes Based on MALDI-TOF MS Platform.
N/ARecruiting
2,860 participants
Started: May 20, 2022 · Completed: Dec 31, 2026
4 conditions1 sponsor1 location
NCT05540587
Efficacy and Safety of Edoxaban in Patients With Atrial Fibrillation and Mitral Stenosis
PHASE2Recruiting
240 participants
Started: May 20, 2022 · Completed: May 20, 2026
4 conditions2 sponsors7 locations
NCT05237869
Blood Flow Restriction & Tennis Elbow Rehab
NARecruiting
250 participants
Started: May 20, 2022 · Completed: Apr 1, 2026
1 condition1 sponsor1 location
NCT05312411
A Phase I Feasibility And Safety Study of Fluorescein-Specific (FITC-E2) CAR T Cells In Combination With Parenterally Administered Folate-Fluorescein (UB-TT170) For Osteogenic Sarcoma
PHASE1Active, not recruiting
21 participants
Started: May 20, 2022 · Completed: May 31, 2040
1 condition2 sponsors1 location
NCT05339685
A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer or Other Solid Tumors
PHASE1Active, not recruiting
82 participants
Started: May 20, 2022 · Completed: Dec 31, 2025
1 condition3 sponsors10 locations